First-Line Vasopressor in Septic Shock
Norepinephrine is the mandatory first-line vasopressor for septic shock, initiated as soon as hypotension persists after fluid resuscitation, targeting a mean arterial pressure (MAP) of 65 mmHg. 1, 2
Initial Management Protocol
- Administer a minimum of 30 mL/kg of crystalloids in the first 3 hours before or concurrent with vasopressor initiation 1, 2
- Start norepinephrine immediately if life-threatening hypotension exists—do not delay waiting to complete full fluid resuscitation 2
- Establish central venous access for safe norepinephrine administration 1, 2
- Place an arterial catheter as soon as practical for continuous blood pressure monitoring 1, 2
Why Norepinephrine Over Other Agents
Norepinephrine demonstrates superior survival compared to dopamine, with an 11% absolute risk reduction in mortality (number needed to treat = 9) and significantly fewer cardiac arrhythmias 3. The Surviving Sepsis Campaign gives norepinephrine a Grade 1B (strong) recommendation based on this mortality benefit 1.
Agents to Avoid as First-Line
- Dopamine: Use only in highly selected patients with low risk of tachyarrhythmias or absolute/relative bradycardia 1, 2. Dopamine is associated with higher mortality and more arrhythmias compared to norepinephrine 2, 3
- Phenylephrine: Not recommended except when norepinephrine causes serious arrhythmias, cardiac output is documented high with persistent hypotension, or as salvage therapy when all other agents fail 1, 2
- Low-dose dopamine for renal protection: Strongly contraindicated—provides no benefit 1, 2
Escalation Strategy for Refractory Hypotension
When norepinephrine alone fails to achieve MAP ≥65 mmHg despite adequate fluid resuscitation:
Second-Line Agent: Vasopressin
- Add vasopressin at 0.01 units/minute, titrating by 0.005 units/minute every 10-15 minutes to a maximum of 0.03 units/minute 2, 4
- Never use vasopressin as monotherapy—it must always be added to norepinephrine 1, 2, 4
- Doses above 0.03-0.04 units/minute should be reserved for salvage therapy only, as higher doses risk cardiac, digital, and splanchnic ischemia 1, 2
- Vasopressin provides a norepinephrine-sparing effect and may reduce complications from high-dose catecholamines 5
Third-Line Agent: Epinephrine
- Add epinephrine (0.05-2 mcg/kg/min) when norepinephrine plus vasopressin fail to achieve target MAP 1, 2
- Epinephrine increases myocardial oxygen consumption and causes transient lactic acidosis through β2-adrenergic stimulation, which can interfere with lactate clearance as a resuscitation endpoint 2, 6
Inotropic Support: Dobutamine
- Add dobutamine (2.5-20 mcg/kg/min) if persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, particularly when myocardial dysfunction is evident 1, 2
- Dobutamine addresses cardiac output rather than vascular tone 2
Adjunctive Therapy for Refractory Shock
- Consider hydrocortisone 200 mg/day IV when hemodynamic stability cannot be achieved despite adequate fluid resuscitation and escalating vasopressor therapy 2, 7
- The decision is based on hemodynamic response, not a predetermined vasopressor dose cutoff 7
- Taper hydrocortisone when vasopressors are no longer required 7
Critical Monitoring Beyond Blood Pressure
- Assess tissue perfusion using lactate clearance, urine output, mental status, and capillary refill 2
- Monitor for signs of excessive vasoconstriction: digital ischemia, decreased urine output, rising lactate, or worsening organ dysfunction despite adequate MAP 2
- Titrate to adequate perfusion markers, not to supranormal blood pressure targets 2
Common Pitfalls to Avoid
- Do not delay norepinephrine for life-threatening hypotension while completing fluid resuscitation 2
- Do not use vasopressin as initial monotherapy—always add it to norepinephrine 1, 2
- Do not escalate vasopressin beyond 0.03-0.04 units/minute except as salvage therapy 1, 2
- Do not use dopamine as first-line—the evidence clearly favors norepinephrine for survival 1, 2, 3
- Do not rely solely on blood pressure numbers—monitor tissue perfusion markers 2